#United States #West Palm Beach #Preventive Care #ProRx Pharma #Gonadorelin

ProRx Pharma Expands Its Product Offerings

In an exciting development for the health and wellness sector, ProRx Pharma, a prominent player in 503B outsourcing, has unveiled six new injectable products to bolster its preventive health portfolio. This expansion aims to meet the rising demand for proactive health solutions among clinics, medical spas, and telehealth providers across the United States.

New Products Designed for Preventive Care

The newly introduced products include Gonadorelin, Liraglutide, Vitamin D3, and Phenylephrine HCl, along with two options for Tri-Mix injections. Each product carries its distinct National Drug Code (NDC) and boasts an extended Beyond Use Date (BUD), effectively enhancing their usability and shelf life for healthcare providers.

Detailed Overview of the Products

1. Gonadorelin (1 mg/mL, 6 mg / 6 mL vial): Widely used in fertility treatments, Gonadorelin is a gonadotropin-releasing hormone agonist that may assist in testosterone production and hormone balance.
2. Liraglutide (custom dosing of 0.75 mg to 3 mg): This GLP-1 receptor agonist is recommended for effective weight management and blood-sugar control, targeting those in need of appetite suppression.
3. Vitamin D3 (50,000 IU/mL, 5 mL vial): A high-dose solution aimed at combating critically low vitamin D levels, which can support various aspects of health such as immune function and mood balance.
4. Tri-Mix #1 (30 mg / 1 mg / 10 mcg/mL, 5 mL vial): Designed for erectile dysfunction (ED) therapy, this formulation promotes improved erectile function.
5. Tri-Mix #2 (30 mg / 2 mg / 20 mcg/mL, 5 mL vial): A stronger variant meant for those requiring enhanced support for ED.
6. Phenylephrine HCl (0.1% 2 mL vial): This critical safety product serves as a remedy for prolonged erections or priapism due to ED treatment.

A Response to Increasing Patient Empowerment

Kurt Lunkwitz, ProRx's Chief Operating Officer, commented on the launch, stating, "Patients are taking charge of their health like never before. Physicians are responding to this trend by integrating wellness therapies into their practices, making preventive health more accessible and streamlined." This proactive approach aligns with a broader movement in healthcare that emphasizes patient autonomy and proactive management of wellness.

Showcasing Innovations at A4M Conference

ProRx is set to showcase its extended line of preventive care products at the A4M 33rd Annual Spring Conference from April 24-26 in West Palm Beach, Florida. Attendees visiting Booth 527 will have the exclusive opportunity to engage with ProRx experts and learn more about the company's commitment to compliance and quality assurance in its product offerings.

About ProRx Pharma

Established as a vital FDA-registered cGMP facility, ProRx Pharma focuses on producing essential compounded medications particularly addressing the FDA drug shortage list. Their commitment to preventive health is evident in the specialization of some of their products. The company is dedicated to ensuring that healthcare providers have access to the necessary medications, especially during times of critical shortages. For further details on their products and services, one can visit ProRx Pharma's official website.

This latest rollout not only highlights ProRx Pharma’s dedication to meeting market demands but also reflects its strategic vision in evolving healthcare solutions to better serve both patients and providers.